Enable job alerts via email!
A clinical-stage biotechnology company is seeking a Process Development Technologist in Oslo. The role includes optimizing manufacturing processes and ensuring compliance with regulatory standards. The ideal candidate has a relevant degree and experience in process development. This is an exciting opportunity to work in a dynamic environment focused on innovative cancer therapies.
Oncoinvent AS is looking for a Process Development Technologist in the Production department at the company manufacturing facility in Oslo. The position is an exciting opportunity to work in an innovative and dynamic start-up company and participate in the development of novel pharmaceuticals.
The Process Development Technologist is responsible for translating laboratory-scale processes into robust, efficient, and commercially viable production processes. The role involves upscaling, optimization, and continuous improvement of production methods to ensure high-quality, cost-effective, and compliant manufacturing. Working closely with the other functional units and Contract Manufacturing Organisation (CMO’s), the technologist bridges the gap between development and full-scale commercial operation.
The successful candidate will collaborate with cross-functional teams and be responsible for ensuring that the production methods of the raw materials, intermediates and drug product (Radspherin) are developed into commercially viable processes.
This position may require hands-on work with radioactive materials. A successful candidate will therefore receive extensive training and is expected to comply with radiation protection and other health and safety procedures during laboratory- and production scale experiments, and GMP production activities.
The holder of this position will be based at Oncoinvent AS, Gullhaugveien 7, 0484 Oslo. The position will report to the Chief Production Officer.
Application deadline: We are reviewing candidates on a rolling basis.
Please submit your application with a motivational letter stating “why Oncoinvent” and what you can contribute to the position as well as an updated CV. Application without this will not be reviewed further.
Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin, uses the alpha-emitting radionuclide radium-224, directly targeting micro-metastases post-surgery, harnessing the benefits of modern radiopharmaceuticals without the complexities of biological targeting. Oncoinvent is investigating the safety and efficacy of Radspherin in a clinical development program in two indications. In addition to the finalized phase 1/2a trial in colorectal cancer, one Phase 1 trial and one randomized Phase 2 trial, both in ovarian cancer are ongoing in the US, UK and Europe. Preliminary clinical efficacy data are highly encouraging, and no serious toxicity or safety concerns have been reported to date. The Oncoinvent team consists of approx. 40 employees and runs a state-of-the-art manufacturing facility to produce drug products for clinical trials in Nydalen, Oslo. Oncoinvent is listed on the Euronext Growth Oslo (ONCIN:OL).